Street Calls of the Week
Investing.com - Cantor Fitzgerald raised its price target on Varonis Systems (NASDAQ:VRNS) to $70 from $63 while maintaining an Overweight rating ahead of the company’s third-quarter 2025 results. The stock currently trades at $62.32, near its 52-week high of $63.90, having surged approximately 45% over the past six months.
The research firm cited Varonis Systems’ continued strong execution through its SaaS transition as a key factor in the decision to increase the price target.
Cantor Fitzgerald noted the company is strengthening its competitive moat and showing steady improvement across key performance indicators.
The firm expressed optimism about Varonis Systems’ long-term growth outlook, which it believes is supported by GenAI-driven data security tailwinds and cross-sell opportunities following the SaaS transition.
Additional growth potential from Varonis Systems’ recent acquisitions of SlashNext and Cyral was also highlighted as a factor in the price target increase.
In other recent news, Varonis Systems reported strong financial results for the second quarter of 2025, showcasing a significant increase in both revenue and annual recurring revenue. Despite the positive financial performance, the company’s stock experienced a slight decline in aftermarket trading. In addition to these earnings results, Varonis introduced a new AI identity protection feature designed for Salesforce Agentforce, enhancing data visibility and control. Analysts have responded positively to these developments, with Cantor Fitzgerald reiterating an Overweight rating for the company. TD Cowen also raised its price target for Varonis Systems to $68 from $62, maintaining a Buy rating. The firm highlighted strong third-quarter trends and expressed confidence in the continued demand for Varonis’s data security solutions. These recent developments indicate a period of growth and innovation for Varonis Systems.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
